Fundz

Ansa Biotechnologies, Inc. reported raising $46.4 Million in an initial SEC Form D filing, from an offering of $9.21 Million

PRIVATEJul 09, 2020

Amount Raised

$46.4 Million

$46.4 Million sold, per SEC Form D (first sale Jul 9, 2020)

Round Type

Seed

EmeryvilleBiotechnology

Who to call at Ansa Biotechnologies, and when

A new round usually means Ansa Biotechnologies is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ansa Biotechnologies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ansa Biotechnologies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ansa Biotechnologies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ansa Biotechnologies

Location

1198 65th St, Suite 250

Emeryville, California, United States

About

Ansa Biotechnologies is redefining DNA synthesis with a bold commitment to quality, customer satisfaction, and success. The Ansa On-Time Guarantee is simple and straightforward: your complete order on time or it’s free. This unprecedented level of service reliability and predictability is made possible by Ansa’s dedicated team of experts and proprietary enzymatic synthesis platform, which can rapidly and accurately produce even the highly complex DNA elements that stymie legacy approaches. Products are delivered as sequence-perfect clonal DNA or sequence-verified linear double-stranded DNA fragments. Headquartered in Emeryville, Calif., Ansa is empowering a global community of scientists to accelerate breakthroughs in healthcare, life sciences, and other industries powered by synthetic DNA.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ansa Biotechnologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts2 people are listed at Ansa Biotechnologies. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Ansa Biotechnologies's next move

See what Strategic adds

Ansa Biotechnologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.